2nd Circ. To Scrutinize Antitrust Causation In Actos Case
The Second Circuit will hear oral arguments Friday in a bid by purchasers of diabetes drug Actos to revive a class action accusing Takeda of delaying generic competition through fraudulent patent...To view the full article, register now.
Already a subscriber? Click here to view full article